Japan Ventures Progress Cell And Gene Candidates For ALS, Severe Conditions

BioJapan Showcases Recent Progress

BioJapan 2024 was joined by numerous ventures with novel modalities in the country (Lisa Takagi)

More from Scrip

More from Focus On Asia